First patients test new cancer drug as last hope
Disease control
Completed
This was the first-ever study in people of a new cancer drug called GEN1056. It tested the drug's safety and aimed to find the right dose for future studies in 26 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to see how sa…
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC